Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neural Transmission
Published in: Journal of Neural Transmission 8/2004

01-08-2004

Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment

Authors: F. Blandini, M. Cosentino, A. Mangiagalli, F. Marino, A. Samuele, E. Rasini, R. Fancellu, C. Tassorelli, C. Pacchetti, E. Martignoni, G. Riboldazzi, D. Calandrella, S. Lecchini, G. Frigo, G. Nappi

Published in: Journal of Neural Transmission | Issue 8/2004

Login to get access
Metadata
Title
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment
Authors
F. Blandini
M. Cosentino
A. Mangiagalli
F. Marino
A. Samuele
E. Rasini
R. Fancellu
C. Tassorelli
C. Pacchetti
E. Martignoni
G. Riboldazzi
D. Calandrella
S. Lecchini
G. Frigo
G. Nappi
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Journal of Neural Transmission / Issue 8/2004
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-004-0123-1

Other articles of this Issue 8/2004

Journal of Neural Transmission 8/2004 Go to the issue

OriginalPaper

GSK-3β in cerebrospinal fluid of schizophrenia patients

OriginalPaper

Comparison of α-dihydroergocryptine and levodopa monotherapy in Parkinson’s disease: assessment of changes in DAT binding with [123I]IPT SPECT

OriginalPaper

Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study

OriginalPaper

Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias

OriginalPaper

Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease

OriginalPaper

Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study